| Nov 30,
2011 | Nov 30,
2012 | Nov 30,
2014 | Nov 30,
2015 | Nov 30,
2016 | Nov 30,
2017 | Nov 30,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Net loss | -72,352 | - | - | - | - | - | -19 | -26 | -1 | -18 | -12 | -65 |
|---|
| Stock-based compensation | - | 3 | 1 | 1 | 3 | 3 | 4 | 3 | 3 | 2 | 1 | 0 |
|---|
| Capital gain, net | - | - | - | - | - | - | - | 0 | -0 | -0 | 0 | - |
|---|
| Loss from deconsolidation of Octomera (see Note 3) | - | - | - | - | - | - | - | - | - | - | - | -5 |
|---|
| Share in net loss of associated companies | - | - | - | - | - | - | -1 | - | 0 | -0 | -2 | -1 |
|---|
| Depreciation and amortization expenses | - | - | - | - | 3 | 3 | 3 | 4 | 1 | 2 | 2 | 2 |
|---|
| Credit loss on convertible loan receivable | - | - | - | - | - | - | - | - | - | - | - | 3 |
|---|
| Impairment of investment | - | - | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Impairment of intangible assets | - | - | - | - | - | - | - | - | - | - | 1 | - |
|---|
| Effect of exchange differences on inter-company balances | - | - | - | - | - | - | - | - | -1 | 0 | 1 | 0 |
|---|
| Net changes in operating leases | - | - | - | - | - | - | - | - | -0 | 0 | 0 | 0 |
|---|
| Interest expense accrued on loans and convertible loans | - | - | - | - | - | - | - | - | - | - | - | -2 |
|---|
| Loss from extinguishment in connection with convertible loan | - | - | - | - | -0 | - | - | - | - | -2 | -0 | -0 |
|---|
| Accounts receivable | - | - | - | 1 | 0 | -0 | 3 | 5 | 1 | 12 | 21 | -30 |
|---|
| Prepaid expenses, other accounts receivable | - | - | - | - | - | - | - | - | 1 | 0 | -0 | -0 |
|---|
| Inventory | - | - | - | 0 | 0 | 0 | 1 | 0 | 0 | -0 | 0 | 0 |
|---|
| Other assets | - | - | - | - | - | - | - | - | - | - | - | -0 |
|---|
| Related parties, net | - | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Accounts payable | 44,513 | 135,791 | 1 | 1 | 1 | -1 | -1 | 5 | 2 | -4 | -1 | 6 |
|---|
| Accrued expenses and other payable | - | - | - | - | - | - | - | - | - | -0 | 2 | 1 |
|---|
| Employee and related payables | - | - | - | - | - | - | - | - | -0 | 0 | -0 | 0 |
|---|
| Deferred taxes, net | - | - | - | - | - | - | - | - | 1 | - | 0 | -0 |
|---|
| Net cash used in operating activities | -189 | -1,051,612 | -1,429,247 | -3 | -4 | -4 | -16 | -13 | -78 | -27 | -25 | -15 |
|---|
| Repayment of convertible loan to related party partners | - | - | - | - | - | - | - | - | - | - | 1 | - |
|---|
| Decrease in loan to associate entities | - | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Increase in loan to associate entities | - | - | - | - | - | - | - | - | - | - | 4 | - |
|---|
| Sale of property, plants and equipment | - | - | - | - | - | - | - | 0 | 0 | - | 0 | - |
|---|
| Purchase of property, plants and equipment | - | 9,679 | 4,746 | 1 | 1 | 1 | 6 | 12 | 2 | 8 | 12 | 2 |
|---|
| Investment in associated company | - | - | - | - | - | - | - | - | - | 0 | - | 1 |
|---|
| Cash acquired from acquisition of Mida | - | - | - | - | - | - | - | - | - | - | 1 | - |
|---|
| Impact to cash resulting from deconsolidation (see Note 3) | - | - | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Increase in cash from business combinations of TLABS and Orgenesis Austria | - | - | - | - | - | - | - | - | - | - | 0 | - |
|---|
| Investment in long-term deposits | - | - | - | - | - | - | - | - | - | - | 0 | 0 |
|---|
| Net cash used in investing activities | - | -20,977 | 2,509 | -1 | -2 | -3 | -6 | -14 | 106 | -12 | -14 | -4 |
|---|
| Proceeds from issuance of shares due to exercise of options and warrants (net of transaction costs) | - | - | - | - | - | - | - | - | 9 | 2 | 2 | 5 |
|---|
| Proceeds from issuance of convertible loans | - | - | 2 | 1 | 2 | 6 | 2 | 11 | 0 | - | 19 | 6 |
|---|
| Proceeds from transaction with redeemable non-controlling interest that do not result in a loss of control, see note 3 | - | - | - | - | - | - | - | 13 | - | - | 20 | 5 |
|---|
| Repayment of convertible loans and convertible bonds | - | - | - | - | - | 4 | 0 | - | 2 | 1 | 2 | 3 |
|---|
| Repayment of short and long-term debt | - | - | - | - | - | - | 0 | 1 | 0 | 0 | 0 | 0 |
|---|
| Proceeds from issuance of loans payable | - | - | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Grant received in respect of third party | - | - | - | - | - | - | - | - | - | - | 1 | - |
|---|
| Transfer of the grant received to third party | - | - | - | - | - | - | - | - | - | - | 1 | - |
|---|
| Net cash provided by financing activities | 55,000 | 1 | 3 | 7 | 2 | 8 | 35 | 24 | 6 | -0 | 40 | 14 |
|---|
| NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | - | - | - | - | - | - | - | -3 | 33 | -39 | 1 | -5 |
|---|
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | - | - | - | - | - | - | - | - | 0 | -0 | -0 | 0 |
|---|
| Right-of-use assets obtained in exchange for new operation lease liabilities | - | - | - | - | - | - | - | 8 | - | - | - | 1 |
|---|
| Increase (decrease) in accounts payable related to purchase of property, plant and equipment | - | - | - | - | - | - | - | - | - | - | -0 | 0 |
|---|
| Loan conversion for Redeemable non-controlling interest (See note 3) | - | - | - | - | - | - | - | - | - | - | 10 | - |
|---|
| Issuance of common stocks in connection with the acquisition of Mida | - | - | - | - | - | - | - | - | - | - | 0 | - |
|---|
| Extinguishment in connection with convertible loan restructuring | - | - | - | - | - | - | - | - | - | - | 0 | 0 |
|---|
| Interest | - | - | - | - | - | - | - | 0 | - | - | 0 | 1 |
|---|